BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30692636)

  • 1. Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression.
    Lin T; Lin TC; McGrail DJ; Bhupal PK; Ku YH; Zhang W; Meng L; Lin SY; Peng G; Tsai RYL
    Oncogene; 2019 May; 38(20):3919-3931. PubMed ID: 30692636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-initiating function of nucleostemin-enriched mammary tumor cells.
    Lin T; Meng L; Li Y; Tsai RY
    Cancer Res; 2010 Nov; 70(22):9444-52. PubMed ID: 21045149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress.
    Wang J; McGrail DJ; Bhupal PK; Zhang W; Lin KY; Ku YH; Lin T; Wu H; Tsai KC; Li K; Peng CY; Finegold MJ; Lin SY; Tsai RYL
    Mol Cancer Res; 2020 May; 18(5):723-734. PubMed ID: 32051231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.
    Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD
    Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
    Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
    Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.
    Huang M; Whang P; Chodaparambil JV; Pollyea DA; Kusler B; Xu L; Felsher DW; Mitchell BS
    J Biol Chem; 2011 Apr; 286(13):11035-46. PubMed ID: 21242306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.
    Sami MM; Hachim MY; Hachim IY; Elbarkouky AH; López-Ozuna VM
    Medicine (Baltimore); 2019 Mar; 98(9):e14744. PubMed ID: 30817632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA resection protein CtIP promotes mammary tumorigenesis.
    Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
    Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers.
    Tumiati M; Munne PM; Edgren H; Eldfors S; Hemmes A; Kuznetsov SG
    Oncogene; 2016 Sep; 35(35):4601-10. PubMed ID: 26820992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
    Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of BCCIP deficiency in mammary tumorigenesis.
    Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
    Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
    Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
    Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
    Shah VV; Duncan AD; Jiang S; Stratton SA; Allton KL; Yam C; Jain A; Krause PM; Lu Y; Cai S; Tu Y; Zhou X; Zhang X; Jiang Y; Carroll CL; Kang Z; Liu B; Shen J; Gagea M; Manu SM; Huo L; Gilcrease M; Powell RT; Guo L; Stephan C; Davies PJ; Parker-Thornburg J; Lozano G; Behringer RR; Piwnica-Worms H; Chang JT; Moulder SL; Barton MC
    Nat Commun; 2021 Sep; 12(1):5389. PubMed ID: 34508101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors.
    Wang J; Ding Q; Fujimori H; Motegi A; Miki Y; Masutani M
    Oncotarget; 2016 Feb; 7(7):7701-14. PubMed ID: 26713604
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bridges AE; Ramachandran S; Pathania R; Parwal U; Lester A; Rajpurohit P; Morera DS; Patel N; Singh N; Korkaya H; Manicassamy S; Prasad PD; Lokeshwar VB; Lokeshwar BL; Ganapathy V; Thangaraju M
    Cancer Res; 2020 Sep; 80(18):3855-3866. PubMed ID: 32665355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
    Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
    Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.